Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Joseph Jongen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
CNS Drugs|June 14, 2017
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying DrugsPeter Joseph Jongen
Interactive Journal of Medical Research|July 13, 2023
Information and Communication Technology Medicine: Integrative Specialty for the Future of MedicinePeter Joseph Jongen
Multiple Sclerosis and Related Disorders|August 9, 2019
Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialitiesPeter Joseph Jongen
Health and Quality of Life Outcomes|March 16, 2017
Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)Peter Joseph Jongen, Wim A Lemmens, Erwin L Hoogervorst, et al.
Journal of Neurology|November 19, 2009
Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1aPeter Joseph Jongen, Christian Sindic, Herwig Carton, et al.
Journal of Medical Internet Research|March 10, 2020
The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient EmpowermentPeter Joseph Jongen, Gezien Ter Veen, Wim Lemmens, et al.
Degenerative Neurological and Neuromuscular Disease|July 5, 2023
Sexual Motivation in Persons with Multiple Sclerosis: A Controlled Cross-Sectional StudyPetra Prinssen, Peter Joseph Jongen, Marco Heerings, et al.
International Journal of MS Care|January 1, 2020
Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MSKarine Wendrich, Pim van Oirschot, Marijn Bart Martens, et al.
Patient Preference and Adherence|April 17, 2013
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatmentPeter Joseph Jongen, Evert Sanders, Cees Zwanikken, et al.
BMC Urology|October 27, 2015
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off pointsPeter Joseph Jongen, Bertil F Blok, John P Heesakkers, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
CNS Drugs|June 14, 2017
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying DrugsPeter Joseph Jongen
Interactive Journal of Medical Research|July 13, 2023
Information and Communication Technology Medicine: Integrative Specialty for the Future of MedicinePeter Joseph Jongen
Multiple Sclerosis and Related Disorders|August 9, 2019
Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialitiesPeter Joseph Jongen
Health and Quality of Life Outcomes|March 16, 2017
Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)Peter Joseph Jongen, Wim A Lemmens, Erwin L Hoogervorst, et al.
Journal of Neurology|November 19, 2009
Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1aPeter Joseph Jongen, Christian Sindic, Herwig Carton, et al.
Journal of Medical Internet Research|March 10, 2020
The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient EmpowermentPeter Joseph Jongen, Gezien Ter Veen, Wim Lemmens, et al.
Degenerative Neurological and Neuromuscular Disease|July 5, 2023
Sexual Motivation in Persons with Multiple Sclerosis: A Controlled Cross-Sectional StudyPetra Prinssen, Peter Joseph Jongen, Marco Heerings, et al.
International Journal of MS Care|January 1, 2020
Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MSKarine Wendrich, Pim van Oirschot, Marijn Bart Martens, et al.
Patient Preference and Adherence|April 17, 2013
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatmentPeter Joseph Jongen, Evert Sanders, Cees Zwanikken, et al.
BMC Urology|October 27, 2015
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off pointsPeter Joseph Jongen, Bertil F Blok, John P Heesakkers, et al.
Pageof 3